michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
We're not going to break down -- Tanu, we're not going to break down each line through here. But there were a number of one-offs in there that otherwise would have put it largely in line with what it was a year ago.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks a lot.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I wouldn't say it's gone back. It's still at an elevated rate. What we have seen though is kind of last year was it was really hot if you will. And on the general, what we've seen is a stronger recovery this year of the professional contractor. So, last year, I would say it was more heavily weighted to the small customers and the DIY this year, our growth on a relative basis is probably what we're seeing is our target customer, the professional contractor is really in a strong position right now.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
For 2021, no, we haven't even closed the OpenSlate acquisition. So, we're not banking on that at all, and Meetrics is not material.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So we have customers for SiPho that are involved in LiDAR. So this is a pure solid state phased array instead of having a movable parts for the laser. That's one area of the SiPho, I mentioned specifically with the press release with Anello that this is a silicon photonics driven [Indecipherable], replacing optical fiber coil. And the bulk of the SiPho though is really -- it's to go into data center, it's to achieve the 400 to 800 gigabit per second capability. And the first and foremost customer that we had press released with was Inphi, as far as then being a SiPho customer and certainly their presence and abilities within having very high data rate capabilities, it's known. They were acquired by Marvell. So those are right now the three major areas that we're involved in.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you. Our next question comes from line of Michael Lavery of Piper Sandler.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So we've got three tournaments coming up. It's going to be a lot of soccer, both on TV and radio. You've got the Euro Cup. You've got Copa America, and then you've got the Gold Cup.
The right number to think about those incrementally as far as revenue is concerned, it's probably an incremental $2 million to $3 million, primarily falling in Q2, but some will bleed into Q3. And again, that will be both on TV and radio.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Great. Thanks for taking the question. I wanted to come back to the conversation around delivery menu price increases. I think you guys mentioned a 4% increase in most recently, but I think the test that you guys were running was substantially higher than that on the delivery price increase, so can you talk a little bit about did you see pushback on the test? And why did you decide on a 4%, why was that the right amount of a price increase to take?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. Francois, why don't you talk about that?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
That's right, yes.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks very much phil. Operator, would you move to the next question.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. This is Michele, I'll take this question. So definitely when we built the countries in the past months and their organizations therefore, we already thinking ahead for the addition of UC. So we did an evaluation country by country, and together with external help of experts and consultants to find the most efficient and effective operating model for each country. Which in a way, allows us to flexibly add personnel sales for medical organization to address that additional target group of the gastroenterologist of course doing in a way, which is efficiency in some countries will add some parallel forces to the existing RA in some others will enlarge the scope of activity, of the hematology team to also address that. And that's very good because this makes us efficient country by country looking at the different systems right there. There are countries like Germany which are office based in countries like France, which are hospital based where all the prescribers are in the same building, in the same place both rheumatologists and [Indecipherable]. So in that way, we have already started, of course, hiring where we need and diligently also considering the different reimbursement time. So we are ready to go say in Germany and will take more time in Italy or Spain, where the reimbursement takes a year longer standard in the industry.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No. I would -- no, in some ways it would be nice if it was, but no. So we still have a large amount -- I mean, the majority of our orders come in and they want us to ship them within a two week period of time. But the highest runner pieces and selected parts are things where if you're not placing orders right now for six months from now or even a year from now, you're liable to run into a real supply constraint. So I would say it's more of a -- it's definitely shifted more toward longer-term perspective, but we -- but it's still -- the majority of our orders still come in and they want us to ship them within the quarter definitely and typically within the month.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. Lee, this is Ryan. I'll talk to liquidity and let Elias talk to the latter question there. But we -- as of March 31, we had $594 million of availability on our revolver. So virtually, the entire revolver balance is open and available plus we had about $60 million of cash on the balance sheet. So just a really strong liquidity position at this point.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good afternoon everyone and thanks for taking my question. I have spend some time looking at your RPL securities today and it looks like it's about $2 billion that you're investment of just under $500 million maybe references is about $200 billion of total loans. Obviously we know what RPLs are, but can you comment on how you acquired those securities, was it kind of just open market now and then, or is there any large structured transaction that put some of those subordinate securities on your books. Thank you.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
The FDA stance on allergic conjunctivitis is interesting and that they're particularly interested in assessing the onset and duration of a therapy in allergic conjunctivitis. The allergen chamber is particularly well suited to assess onset and duration because patients are continuously exposed to allergen over three and a half hours. And the particular primary endpoint, as I mentioned in my prepared remarks, is the achievement of statistical significance between drug and vehicle over a majority or, I should say, at a majority of time points in a prespecified range. As you can see in our corporate deck, we specified a range that in Phase II, was highly statistically significant between drug and vehicle.
Within that range, the FDA will be looking not only for the achievement of majority of endpoints or time points, but also the onset of the drug and how long the drug acts within that range. Based on the Phase II data, we would expect the onset to be the first time point and the duration to be the last time point. But that is sort of the rubric that the FDA is using to assess the drug.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I'll start and then I'll ask Mark to talk a little bit about some of our renewable fuels activities in his portfolio. We have good shareholder support in alignment for our strategy and objectives of higher returns lower carbon. That's both lowering the carbon intensity of our traditional operations and then growing low-carbon businesses that leverage our strengths our capabilities assets and customer relationships. And they target the sectors that cannot be easily electrify, the hard to abate sector.
So this is things like air travel, industrial emissions, heavy duty transport. The $10 billion of capital is connected to some pretty ambitious targets that go out to 2030. So it's 150,000 tons per annum of hydrogen, 25 million tons per year of carbon capture and storage. That's all consistent with that capital guidance.
So we are more in the execution mode and getting it done versus, let's say, competing on capex targets. It's not easy to do. These are ambitious targets. They have challenges, lots of opportunity.
But let me ask Mark to talk a bit about his portion of that on renewable fuels.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. I think our thinking hasn't really changed relative to bank M&A. I don't think that you can win this race by just getting larger, bigger isn't better, better is better. It's absolutely the way we think about this. There could be deals that make sense. There are a lot of deals that probably don't. We continue to be I think pretty cautious about any activity given all the internal focus we have on getting this feature core project behind us.
As we emerge from that, I think we'll have certainly an opportunity to do things that would be appealing to customers and it will provide some capabilities that might be incrementally enticing to the sellers. But at the end of the day, we just want to get through that project, clear our minds and then look at the economics of what's out there. And if it makes sense and if they particularly end in market consolidation that improves incrementally economics that, that's something we certainly look at. But it's not, it's not going to be a driver of our not -- strategically, it's not something that's kind of front burner for us.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you, Catherine. Jim, do you want to comment?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure, Marc, really insightful questions. Thanks. So, Dusty, why don't you speak to our integrated freezer platform sales team. Now that we've stitched these together, and all these folks now have an opportunity to tweet for really any opportunity.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So on NII, as we mentioned, look, the impact of negative interest rate and the inflow of deposits, it's there. But you see the management action that we have taken. We're taking advantage and making sure we achieve the TLTRO benefit, negative rates-charging behavior and other fees increases that we have. And hopefully, we benefit from the improving yield curve environment.
So these are things that are -- actions that we are taking to make sure that our net interest income is remaining resilient. OK? And in terms of the opex, as Steven mentioned before, we don't want to give you a overarching transformation plan, but we want to announce plans as things become execution certain and that's what you've seen in the first quarter as well. So we will give you transparency on actions taken on a quarter-by-quarter basis.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Good afternoon, and congratulations in the results. I wonder to see if I could ask one product and one financial question, if I may. So on the product side, just a follow-up on the last question regarding Pixie. I was wondering if you could just frame for us how important is the EDPS capability that you have? And are there other use cases that you could sort of apply Pixie's technology to?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Thank you for question. This is Damon. So the short answer is yes. As you know with a REIT, there are some restrictions on what you can or cannot do as a publicly traded REIT. So, we do think now being a C Corp, again, we were C Corp once upon a time too before 2013. It could open some opportunities to where we provide not only the real estate and maybe the services for certain solutions. So for example, I mentioned earlier, the new project in Kansas that has a very large infirmary unit again, largest actually unit in the state of Kansas serving their correctional institution or correctional system. There could be a case where we can maybe do a medical, kind of, oriented solution for certain jurisdiction, maybe that's an infirmary, maybe that's a mental health or substance abuse type facility. So, it gives us greater flexibility of providing, kind of, healthcare related services that we weren't able to do as a REIT.
Anything you would add to that David?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
No.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yeah. No. I am incredibly proud of the execution of the team. This is not ordinary times or environment that we are operating in. But we are using NBS Next and -- in our businesses to meet this incredible demand. And it plays out in many different ways in multiple businesses across the company. NBS Next fundamentally is all about making choices to drive growth. And what you begin to see is, for example, in some of our businesses understanding what are your greatest growth opportunities and disproportionately investing in them is one way it shows up in this great execution.
You'll see our team standardizing product offering, reducing complexity, streamlining and dedicating products to the most important products in the business, prioritizing our best growth opportunities, our best customers. So lots of different ways be it quality, be it manufacturing capacity, be it conversion costs, be it selecting the right end markets to choose to play. And also treating very differently unattractive opportunities in the business is really how this is playing out. I am really happy about the progress we are making. And I wouldn't say I'm surprised, but I am excited about the fact that the teams are doing one heck of a job really converting orders to shipments, shipments to profitable growth for all of us.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So David, it's good to hear you. A couple of things on the scanner data. Overall, we were a couple of weeks early on our back-to-school promotion.
It's about at equal level that it was a year ago, which is a little bit early. So I think what we're seeing now is going to a little bit moderate, I'd say, as we go through the year. I think your math on the full year number feels generally good. But I think what's most important is we feel terrific about the underlying consumer trends that we're seeing that supports the sustained growth.
As we went through COVID, we had the decrease in mobility, the increase in home snacking as we get to a more normalized rate, what we're seeing is increased mobility, improving our on-the-go and immediate consumption sales. And even with the return of that mobility, we're still seeing an elevated level of consumers in the home. And when consumers are in their home more, they're snacking more. So we have a portfolio, as I mentioned in my prepared remarks, that are -- is well positioned for what we believe are some sustained consumer trends around indulgent snacking and how they snack.
The majority of our portfolio is individually portioned. It's portion controlled, but it's available in the home and on the go, and we're well positioned for sustained growth there. But I believe you have your numbers correct.

    Prediction (one of UP, DOWN, SAME): SAME